MD1051C2 - Remediu antiherpetic - Google Patents
Remediu antiherpeticInfo
- Publication number
- MD1051C2 MD1051C2 MD96-0372A MD960372A MD1051C2 MD 1051 C2 MD1051 C2 MD 1051C2 MD 960372 A MD960372 A MD 960372A MD 1051 C2 MD1051 C2 MD 1051C2
- Authority
- MD
- Moldova
- Prior art keywords
- antiherpetic
- remedy
- pavstim
- furostan
- virusology
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Invenţia se referă la virusologia medicală, la mijloacele de suprimare a activităţii infecţioniste a viruşilor herpesului.Esenţa invenţiei constă în utilizarea în calitate de remediu antiherpetic a soluţiei de pavstim- 3-O-[β-D-xilopiranozil-(1→3)]-O-β-D-glucopiranozil-(1→2)-O-β-D-glucopiranozil-(1→4)-O-β-D-glucopiranozid-(25R)-furostan-5α-2α, 3β, 22α, 26-tetraol-26-O-β-D-glucopiranozid)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MD96-0372A MD1051C2 (ro) | 1996-12-02 | 1996-12-02 | Remediu antiherpetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MD96-0372A MD1051C2 (ro) | 1996-12-02 | 1996-12-02 | Remediu antiherpetic |
Publications (1)
Publication Number | Publication Date |
---|---|
MD1051C2 true MD1051C2 (ro) | 1999-05-31 |
Family
ID=62129543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MD96-0372A MD1051C2 (ro) | 1996-12-02 | 1996-12-02 | Remediu antiherpetic |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD1051C2 (ro) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1473G2 (ro) * | 1998-06-02 | 2001-05-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Remediu antiherpetic |
MD2053C2 (ro) * | 2001-07-10 | 2003-07-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Remediu cu acţiune interferonogenă |
MD315Z (ro) * | 2010-09-22 | 2011-09-30 | Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы | Procedeu de tratare a seminţelor de ceapă |
MD995Z (ro) * | 2015-01-27 | 2016-08-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Metodă de tratament al infecţiei cu virusul Herpes simplex de tip 1 şi 2 |
-
1996
- 1996-12-02 MD MD96-0372A patent/MD1051C2/ro not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
Preparate chimice şi biologie de protecţie şi stimulare a creşterii plantelor. Chişinău, Ştiinţa, 1977, p. 90 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1473G2 (ro) * | 1998-06-02 | 2001-05-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Remediu antiherpetic |
MD2053C2 (ro) * | 2001-07-10 | 2003-07-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Remediu cu acţiune interferonogenă |
MD315Z (ro) * | 2010-09-22 | 2011-09-30 | Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы | Procedeu de tratare a seminţelor de ceapă |
MD995Z (ro) * | 2015-01-27 | 2016-08-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Metodă de tratament al infecţiei cu virusul Herpes simplex de tip 1 şi 2 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9606732A (es) | Compuestos terapeuticos. | |
CA2293470A1 (en) | Benzimidazole derivatives | |
ES8801303A1 (es) | Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido. | |
UA29429C2 (uk) | Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини | |
MX9504415A (es) | Eteres antivirales de isoesteres de sustrato de proteasa de aspartato. | |
YU18899A (sh) | L-nukleozidi purina, njihovi analogoni i primena | |
GR3017686T3 (en) | Fluorocytidine derivatives, their preparation and medical preparations containing them. | |
MX9805441A (es) | Compuestos terapeuticos. | |
MD1051C2 (ro) | Remediu antiherpetic | |
MY105855A (en) | Therapeutic nucleotides. | |
HUP9900945A2 (hu) | Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában | |
CA2189705A1 (en) | Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment of the haematopoetic cell system | |
ZA858237B (en) | Ing 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamine method of medical treatment of human viral diseases utiliz | |
AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
GB2277265B (en) | Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema | |
MY110074A (en) | Pharmacuetical formulation. | |
HUP9901299A2 (hu) | Attenuált, nemimmunogén poxvírusokból vagy parapoxvírusokból előállított multipotens parapox immunitást előidéző gyógyszerek használatának új indikációi | |
GB9114939D0 (en) | Pharmaceutical formulation | |
MY111746A (en) | Therapeutic nucleosides. | |
MD980129A (ro) | Remediu antiherpetic | |
AU7111587A (en) | Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use | |
AU2065488A (en) | The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent | |
AU2211592A (en) | Method of treatment for latent virus infection | |
MD742C2 (ro) | Remediu cu activitate regenerativă | |
HUT63552A (en) | Medical cosmetic permanently neutralizing human body odour |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |